Evidence map›Paper›PMID 10713961›Full record

ArticleThe Journal of physiology2000

Inhibition of KCNQ1-4 potassium channels expressed in mammalian cells via M1 muscarinic acetylcholine receptors.

A A Selyanko, J K Hadley, I C Wood, F C Abogadie, T J Jentsch, D A Brown

Open access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 164 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Cholinergic Stimulation Modulates the Functional Composition of CA3 Cell Types in the Hippocampus.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  7. Regulation of Neurotransmitter Release by KAdvances in neurobiology · 2023
    Article
  8. Article
  9. Article
  10. The KNeuroscience · 2021
    Article
  11. Activation of KCNQ4 as a Therapeutic Strategy to Treat Hearing Loss.International journal of molecular sciences · 2021
    Review
  12. Article
  13. Article
  14. PIPProceedings of the National Academy of Sciences of the United States of America · 2020
    Review
  15. A PIPCommunications biology · 2020
    Article
  16. The Role of KFrontiers in physiology · 2020
    Review
  17. Review
  18. Article
  19. Article
  20. The KThe Journal of physiology · 2019
    Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

A A SelyankoDepartment of Pharmacology, University College London, UK. a.selyanko@ucl.ac.uk
J K Hadley
I C Wood
F C Abogadie
T J Jentsch
D A Brown
University College London · GBUniversität Hamburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

1. KCNQ1-4 potassium channels were expressed in mammalian Chinese hamster ovary (CHO) cells stably transfected with M1 muscarinic acetylcholine receptors and currents were recorded using the whole-cell perforated patch technique and cell-attached patch recording. 2. Stimulation of M1 receptors by 10 microM oxotremorine-M (Oxo-M) strongly reduced (to 0-10%) currents produced by KCNQ1-4 subunits expressed individually and also those produced by KCNQ2 + KCNQ3 and KCNQ1 + KCNE1 heteromers, which are thought to generate neuronal M-currents (IK,M) and cardiac slow delayed rectifier currents (IK,s), respectively. 3. The activity of KCNQ2 + KCNQ3, KCNQ2 and KCNQ3 channels recorded with cell-attached pipettes was strongly and reversibly reduced by Oxo-M applied to the extra-patch membrane. 4. It is concluded that M1 receptors couple to all known KCNQ subunits and that inhibition of KCNQ2 + KCNQ3 channels, like that of native M-channels, requires a diffusible second messenger.

Indexed as

Potassium Channel BlockersPotassium Channels, Voltage-GatedAnimalsCHO CellsCricetinaeKCNQ1 Potassium ChannelKCNQ2 Potassium ChannelKCNQ3 Potassium ChannelKCNQ Potassium ChannelsMuscarinic AgonistsOxotremorinePatch-Clamp TechniquesPotassium ChannelsReceptor, Muscarinic M1Receptors, MuscarinicStimulation, ChemicalKCNQ1 Potassium ChannelKCNQ2 Potassium ChannelKCNQ3 Potassium ChannelKCNQ Potassium ChannelsMuscarinic AgonistsOxotremorineoxotremorine MPotassium Channel BlockersPotassium ChannelsPotassium Channels, Voltage-GatedReceptor, Muscarinic M1Receptors, Muscarinic

Identifiers

PMID10713961
PMCPMC2269765
OpenAlexW2066008360

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.